PR Newswire (Mon, 8:00AM)
Quote & Headlines
Market Currents
StockTalk
Today
5d
1m
3m
1y
5y
10y
52wk high:
52wk low:
EPS:
PE:
Div Rate:
Yield:
Market Cap:
Volume:
107 people get CEMP articles and Market Currents by email alert.
Get email alerts on CEMP »
HEADLINES:
ALL
|
PRO
|
FOCUS
|
RELATED
|
TRANSCRIPTS
|
NEWS & PR
-
PR Newswire (Apr 25, 2013)
-
PR Newswire (Apr 24, 2013)
-
-
PR Newswire (Feb 28, 2013)
-
PR Newswire (Feb 26, 2013)
-
PR Newswire (Feb 5, 2013)
-
-
PR Newswire (Dec 5, 2012)
-
PR Newswire (Nov 9, 2012)
-
PR Newswire (Nov 8, 2012)
To learn more about Seeking Alpha Pro, click here.
-
-
-
-
-
-
-
IPO Preview: Durata TherapeuticsIPOdesktop • Wed, Jul 18, 2012
-
2012 Biotech IPOs: Age Of The Dreamers?Bioassociate Consulting • Wed, Jul 4, 2012 -
-
-
-
-
2 Life Sciences IPOs Debut Below TargetThe Burrill Report • Sun, Feb 5, 2012 -
-
-
PR Newswire (Apr 25, 2013)
-
PR Newswire (Apr 24, 2013)
-
PR Newswire (Feb 28, 2013)
-
PR Newswire (Feb 26, 2013)
-
PR Newswire (Feb 5, 2013)
-
PR Newswire (Dec 5, 2012)
-
PR Newswire (Nov 9, 2012)
-
PR Newswire (Nov 8, 2012)
-
PR Newswire (Oct 18, 2012)
-
PR Newswire (Oct 8, 2012)
CEMP vs. ETF Alternatives
Company Description
We are a clinical-stage pharmaceutical company focused on developing antibiotics to meet critical medical needs in the treatment of bacterial infectious diseases, particularly respiratory tract infections and chronic and acute staphylococcal infections. Our lead program is CEM-101, which we are... More
- All
- | Earnings
- | Dividends
- | M&A
- | On the move
- Thursday, April 25, 6:46 PM Cempra (CEMP): Q1 EPS of -$0.42 misses by $0.07. (PR) Comment! [Earnings, Breaking News]
- Thursday, February 28, 5:17 PM Cempra (CEMP): Q4 EPS of -$0.26 beats by $0.06. (PR) Comment! [Earnings, Breaking News, Healthcare]
There are no StockTalks on this stock yet.